These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 19916268

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The human immunodeficiency virus. In search of an effective prophylaxis].
    Ciufecu C.
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):147-50. PubMed ID: 9116404
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Trial suggests vaccines could aid HIV therapy.
    Check E.
    Nature; 2003 Apr 17; 422(6933):650. PubMed ID: 12700722
    [No Abstract] [Full Text] [Related]

  • 27. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
    Yang OO.
    AIDS; 2008 Jan 30; 22(3):325-31. PubMed ID: 18195558
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The HIV vaccine pipeline, from preclinical to phase III.
    Schultz AM, Bradac JA.
    AIDS; 2001 Jan 30; 15 Suppl 5():S147-58. PubMed ID: 11816163
    [No Abstract] [Full Text] [Related]

  • 30. Mapping the future of HIV vaccines.
    Nabel GJ.
    Nat Rev Microbiol; 2007 Jul 30; 5(7):482-4. PubMed ID: 17571457
    [No Abstract] [Full Text] [Related]

  • 31. Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen.
    Chanda PK, Natuk RJ, Dheer SK, Lubeck MD, Bhat BM, Mason BB, Greenberg L, Mizutani S, Davis AR, Hung PP.
    Int Rev Immunol; 1990 Jul 30; 7(1):67-77. PubMed ID: 2132880
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T, Moffat JM, Venturi V, Davenport MP, Doherty PC, Turner SJ, Stambas J.
    Vaccine; 2009 Nov 12; 27(48):6755-61. PubMed ID: 19744584
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. AIDS/HIV. A STEP into darkness or light?
    Moore JP, Klasse PJ, Dolan MJ, Ahuja SK.
    Science; 2008 May 09; 320(5877):753-5. PubMed ID: 18467578
    [No Abstract] [Full Text] [Related]

  • 39. [HIV eradication--facts and fiction].
    Jaeger H, Wolf E.
    MMW Fortschr Med; 2008 Apr 28; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.